Nan Fung Group Holdings Ltd - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 34 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
Nan Fung Group Holdings Ltd ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$775,496
+4.4%
49,0820.0%0.63%
+32.2%
Q2 2023$743,101
-30.4%
49,082
-33.3%
0.48%
-34.6%
Q1 2023$1,066,939
+7.2%
73,5820.0%0.73%
+6.0%
Q4 2022$994,829
-55.4%
73,582
-48.0%
0.68%
-51.9%
Q3 2022$2,232,000
+5.6%
141,593
-18.4%
1.42%
-1.9%
Q2 2022$2,114,000
+29.7%
173,5820.0%1.45%
+87.8%
Q1 2022$1,630,000173,5820.77%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$7,706,60860.04%
MPM ASSET MANAGEMENT LLC 4,425,784$67,006,37032.86%
5AM Venture Management, LLC 4,408,379$66,742,85816.63%
StepStone Group LP 761,277$11,525,7342.13%
TCG Crossover Management, LLC 584,955$8,856,2191.45%
Redmile Group, LLC 1,311,572$19,857,2000.76%
Nan Fung Group Holdings Ltd 49,082$743,1010.48%
Baker Brothers Advisors 4,865,819$73,668,5000.43%
Corton Capital Inc. 18,067$273,5340.13%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,589,7000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders